作者: Craig J. Mossman , Sheila M. Zipfel , John O. Link , Soon H. Woo
DOI:
关键词:
摘要: The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S therefore useful treating diseases mediated by these proteases. pharmaceutical compositions comprising processes for preparing them.